Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial.
Tonelli R, Pischiutta F, Elice F, Zanier ER, Grisendi G, Astori G, Samarelli AV, Bruzzi G, Manicardi L, Spano C, Nattino G, Signorini F, Bernardi M, Catanzaro D, Merlo A, Lisi I, Pasetto L, Bonetto V, Fiammenghi L, Boschi L, Guidi S, Candini O, Zoerle T, Dander E, D'Amico G, De Pierri F, Maur M, Pettorelli E, Ruggieri V, Cerri S, Mari G, De Berardis G, Mighali P, Baschieri MC, Lazzari L, Bambi F, Ciccocioppo R, Clini E, Dominici M; RESCAT study group.
Tonelli R, et al. Among authors: fiammenghi l.
Cytotherapy. 2025 Apr 7:S1465-3249(25)00677-2. doi: 10.1016/j.jcyt.2025.04.059. Online ahead of print.
Cytotherapy. 2025.
PMID: 40353787
Free article.